Multi-omics analysis to decipher the molecular link between chronic exposure to pollution and human skin dysfunction.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 09 2021
Historique:
received: 24 03 2021
accepted: 03 08 2021
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

Environmental pollution is composed of several factors, namely particulate matter (PM

Identifiants

pubmed: 34526566
doi: 10.1038/s41598-021-97572-1
pii: 10.1038/s41598-021-97572-1
pmc: PMC8443591
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18302

Informations de copyright

© 2021. The Author(s).

Références

Microbiome. 2020 Jun 26;8(1):100
pubmed: 32591010
Int J Public Health. 2015 Jul;60(5):619-27
pubmed: 26024815
OMICS. 2016 Nov;20(11):615-626
pubmed: 27828771
Dermatol Ther. 2004;17 Suppl 1:43-8
pubmed: 14728698
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18410-18415
pubmed: 31451642
J Allergy Clin Immunol. 2016 Nov;138(5):1491-1494.e7
pubmed: 27576125
Brief Bioinform. 2018 Nov 27;19(6):1356-1369
pubmed: 29106465
Trends Pharmacol Sci. 2009 Aug;30(8):411-20
pubmed: 19608284
Environ Pollut. 2017 Nov;230:163-177
pubmed: 28651088
Curr Environ Health Rep. 2020 Mar;7(1):58-64
pubmed: 31927691
Life Sci. 2016 May 1;152:126-34
pubmed: 27018067
Int J Cosmet Sci. 2016 Jun;38(3):217-23
pubmed: 26291783
J Occup Environ Med. 2019 Dec;61 Suppl 12:S73-S81
pubmed: 31800453
J Dermatol Sci. 2018 Sep;91(3):239-249
pubmed: 29857962
Sci Rep. 2017 Sep 5;7(1):10567
pubmed: 28874721
Sci Total Environ. 2014 Oct 1;494-495:84-96
pubmed: 25037047
Arch Toxicol. 2017 Jun;91(6):2331-2341
pubmed: 28378121
Nature. 2019 May;569(7758):655-662
pubmed: 31142855
Nature. 2013 Jun 20;498(7454):367-70
pubmed: 23698366
Curr Med Chem. 2018;25(40):5469-5486
pubmed: 28925870
Biostatistics. 2014 Jul;15(3):569-83
pubmed: 24550197
PLoS One. 2015 Aug 20;10(8):e0135749
pubmed: 26291610
Acta Derm Venereol. 2002;82(3):170-3
pubmed: 12353705
Nat Genet. 2018 Jun;50(6):790-795
pubmed: 29808030
J Invest Dermatol. 2010 Dec;130(12):2719-26
pubmed: 20664556
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2120-9
pubmed: 25825778
Indian J Dermatol Venereol Leprol. 2014 Sep-Oct;80(5):395-401
pubmed: 25201838
Pharmacogenomics J. 2015 Apr;15(2):189-95
pubmed: 25156213
Microbiology (Reading). 2015 Jun;161(6):1161-74
pubmed: 25787873
J Anal Toxicol. 2009 Jul-Aug;33(6):301-9
pubmed: 19653933
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e118-e129
pubmed: 33123723
Crit Rev Clin Lab Sci. 2001 Aug;38(4):263-355
pubmed: 11563810
BMC Biol. 2019 Jun 12;17(1):47
pubmed: 31189482
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2326-32
pubmed: 26289769
Nat Rev Drug Discov. 2008 Jan;7(1):41-53
pubmed: 18172439
J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1496-1505
pubmed: 30897234
Sci Rep. 2015 Aug 03;5:12689
pubmed: 26235394
Front Endocrinol (Lausanne). 2019 Jul 31;10:504
pubmed: 31417492
J Allergy Clin Immunol. 2019 Jun;143(6):2108-2119.e12
pubmed: 30578876
Hautarzt. 2003 Sep;54(9):809-17
pubmed: 12955256
Environ Int. 2018 Dec;121(Pt 2):1341-1354
pubmed: 30420128
Trends Pharmacol Sci. 2013 Feb;34(2):136-43
pubmed: 23123095
Mol Cell. 2019 Mar 21;73(6):1097-1114
pubmed: 30878283
Int J Hyg Environ Health. 2014 Jan;217(1):23-33
pubmed: 23567252
J Chem Ecol. 2018 Dec;44(12):1158-1169
pubmed: 30350228
Arch Toxicol. 2018 Oct;92(10):3061-3075
pubmed: 30159663
Arch Toxicol. 2017 Aug;91(8):2813-2825
pubmed: 28011991
Nat Microbiol. 2020 Jan;5(1):108-115
pubmed: 31686026
Br J Dermatol. 1987 Aug;117(2):175-83
pubmed: 2958076
Dermatol Ther (Heidelb). 2014 Jun;4(1):71-81
pubmed: 24643868
J Microbiol Biotechnol. 2012 Jan;22(1):84-91
pubmed: 22297223
Int J Cosmet Sci. 2015 Jun;37(3):329-38
pubmed: 25655908
FEMS Microbiol Lett. 2014 Jul;356(1):89-96
pubmed: 24861375
Nurs Res. 2017 Mar/Apr;66(2):152-163
pubmed: 28114181

Auteurs

Namita Misra (N)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France. namita.misra@rd.loreal.com.

Cécile Clavaud (C)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Florent Guinot (F)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Nasrine Bourokba (N)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Stephanie Nouveau (S)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Sakina Mezzache (S)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Paul Palazzi (P)

Human Biomonitoring Research Unit, Luxembourg Institute of Health, Strassen, Luxemburg.

Brice M R Appenzeller (BMR)

Human Biomonitoring Research Unit, Luxembourg Institute of Health, Strassen, Luxemburg.

Arthur Tenenhaus (A)

CentraleSupelec Laboratoire des Signaux et Systemes, Université Paris-Saclay, CNRS, Gif-sur-Yvette, France.
Brain and Spine Institute, Paris, France.

Marcus H Y Leung (MHY)

School of Energy and Environment, City University of Hong Kong, Kowloon, Hong Kong SAR, China.

Patrick K H Lee (PKH)

School of Energy and Environment, City University of Hong Kong, Kowloon, Hong Kong SAR, China.

Philippe Bastien (P)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Luc Aguilar (L)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Nükhet Cavusoglu (N)

Research and Innovation, L'Oréal SA, Aulnay Sous Bois, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH